These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3260844)

  • 1. Factors influencing the cytotoxicity of anti-bacterial sera for lymphocytes from ankylosing spondylitis patients.
    Archer JR; Stubbs MM; Geczy AF
    Clin Exp Rheumatol; 1988; 6(1):35-9. PubMed ID: 3260844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
    Singh B; Milton JD; Woodrow JC
    Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
    McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
    Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA B27, ankylosing spondylitis, and some normal rabbit sera.
    Mackintosh P; Pease P
    Ann Rheum Dis; 1982 Aug; 41(4):433-4. PubMed ID: 6981389
    [No Abstract]   [Full Text] [Related]  

  • 5. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of klebsiella capsular antisera on lymphocytes from patients with ankylosing spondylitis.
    Shinebaum R; Cooke EM; Siegerstetter J; Wright V
    J Med Microbiol; 1981 Nov; 14(4):451-6. PubMed ID: 7310846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients.
    Beukelman CJ; van Leeuwen A; Aerts PC; van Kregten E; van Bree S; van Rood JJ; Willers JM; van Dijk H
    Br J Rheumatol; 1988; 27 Suppl 2():58-60. PubMed ID: 3261191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
    Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R
    Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blind confirmation of Geczy factor in ankylosing spondylitis.
    van Rood JJ; van Leeuwen A; Ivanyi P; Cats A; Breur-Vriesendorp BS; Dekker-Saeys AJ; Kijlstra A; van Kregten E
    Lancet; 1985 Oct; 2(8461):943-4. PubMed ID: 2865436
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 12. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera.
    Avakian H; Welsh J; Ebringer A; Entwistle CC
    Br J Exp Pathol; 1980 Feb; 61(1):92-6. PubMed ID: 6990955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
    Baines M; Ebringer A; Avakian H; Samuel D; James DC
    Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis.
    McGuigan LE; Prendergast JK; Geczy AF; Edmonds JP; Bashir HV
    Ann Rheum Dis; 1986 Jul; 45(7):566-71. PubMed ID: 3527085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model.
    McLean IL; Adams DD; Highton J
    J Clin Lab Immunol; 1985 Nov; 18(3):123-7. PubMed ID: 3878886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
    van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
    Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy.
    Beukelman CJ; Quarles van Ufford HC; van Bree FP; Aerts PC; Nieuwenhoff C; Reerink G; van Leeuwen A; van Dijk H
    Scand J Rheumatol Suppl; 1990; 87():74-9; discussion 79-80. PubMed ID: 2259890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

  • 20. The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis.
    Alexander K; Edwards C; Misko IS; Geczy AF; Bashir HV; Edmonds JP
    Clin Exp Immunol; 1981 Jul; 45(1):158-64. PubMed ID: 6171370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.